SAN FRANCISCO, California — It was a battle between two ADP-receptor blockers as well as between IV and oral antiplatelet therapy at coronary interventions: a >11 000-patient randomized trial found ...
Antiplatelet therapy, either aspirin alone or dual therapy with aspirin and clopidogrel, given after percutaneous coronary intervention (PCI) can lower the occurrence of adverse thrombotic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results